Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Can a negative PSMA PET/CT limit the indication for lymphadenectomy in patients with localized moderate- and high-risk prostate cancer?

Created on 04 Nov 2026

Authors

Kristýna Dianová, Vladimír Šámal, Vít Paldus

Published in

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. Volume 39. Issue 5. Pages 320-324.

Abstract

The aim is to summarize recent findings on the diagnostic value of Ga-68 PSMA PET/CT imaging in patients with intermediate- and high-risk prostate cancer scheduled for radical prostatectomy and its impact on decision-making regarding simultaneous performance of pelvic lymphadenectomy. The focus is on sensitivity, specificity, and negative predictive value of this imaging modality in detecting lymph node metastases; the limitations of the examination are discussed, and situations in which the results may influence therapeutic management are outlined. Based on currently available data, a negative PSMA PET/CT result significantly reduces the probability of lymph node involvement. However, despite a negative PSMA PET/CT scan, risk of lymph node involvement remains approximately 10% in intermediate-risk tumors and 20-40% in high-risk tumors. Nomograms for estimating the risk of lymph node involvement are already available and incorporate PSMA PET/CT findings into their calculations. Therefore, the decision to perform lymphadenectomy should be individualized according to the patient's risk profile.

PMID:
42975993
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement